|
US2008063722A1
|
|
Composition of a Spray-Dried Powder for Pulmonary Delivery of a Long Acting Neuraminidase Inhibitor (LANI)
|
|
US2007123449A1
|
|
High load particles for inhalation having rapid release properties
|
|
WO2006065722A2
|
|
Compositions and methods for pulmonary conditions
|
|
WO2005077338A1
|
|
Particles for inhalation rapid release properties
|
|
US2005008633A1
|
|
Chemical and physical modulators of bioavailability of inhaled compositions
|
|
CA2478801A1
|
|
Method for administration of growth hormone via pulmonary delivery
|
|
WO03072080A1
|
|
Inhalable formulations for sustained release
|
|
WO03043603A1
|
|
Particulate compositions for improving solubility of poorly soluble agents
|
|
EP1458361A2
|
|
Compositions for sustained action product delivery
|
|
US7008644B2
|
|
Method and apparatus for producing dry particles
|
|
EP1797902A2
|
|
Particles for inhalation having sustained release properties
|
|
EP1345629A2
|
|
Particles for inhalation having sustained release properties
|
|
WO0213897A2
|
|
Inhalation device and method
|
|
US2002141946A1
|
|
Particles for inhalation having rapid release properties
|
|
US2002058009A1
|
|
Pulmonary delivery in treating disorders of the central nervous system
|
|
US2003017113A1
|
|
Control of process humidity to produce large, porous particles
|
|
US6766799B2
|
|
Inhalation device
|
|
US2001036481A1
|
|
Modulation of release from dry powder formulations
|
|
US6514482B1
|
|
Pulmonary delivery in treating disorders of the central nervous system
|
|
US6749835B1
|
|
Formulation for spray-drying large porous particles
|
